More on MIRA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mira Pharma (NQ:MIRA)
Delayed: 0.55 +0.02 (3.77%)
Prev. Close $0.53  
Open$0.54 
52 Wk High$0.04 
52 Wk Low$0.00 
Day High$0.57 
Day Low$0.53 
P/E N/A  
EPS$0.00 
Volume86,797 


Oct 22, 2026 08:05 AM MIRA Pharmaceuticals' MIRA-55 shows pain relief in preclinical study
Oct 22, 2026 08:00 AM Form 8-K MIRA PHARMACEUTICALS, For: Oct 22
Oct 22, 2026 08:00 AM MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
Sep 17, 2026 08:31 AM Form 8-K MIRA PHARMACEUTICALS, For: Sep 17
Sep 17, 2026 08:30 AM MIRA Pharmaceuticals submits Ketamir-2 Phase 2a protocol for IRB review
Sep 17, 2026 08:30 AM MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
Sep 17, 2026 07:46 AM Maxim Group Starts MIRA Pharmaceuticals Inc (MIRA) at Buy
Sep 16, 2026 04:31 PM Form 8-K MIRA PHARMACEUTICALS, For: Sep 11
Sep 3, 2026 08:02 AM Miravalles Gold Corp. Files NI 43-101 Technical Report for Fairfield Gold Project, Nayarit, Mexico
Sep 1, 2026 08:03 AM MIRA Pharmaceuticals reports positive toxicology data for MIRA-55 pain drug
View All Articles

Entities mentioned with MIRA

View All Entities